Practitioners
Patients
WEBINAR
For clinicians managing polypharmacy patients, drug-drug interactions (DDIs) pose a significant challenge. Certain medications can inhibit or induce metabolic pathways, leading to reduced efficacy, heightened toxicity, or unexpected side effects.
This advanced CPD webinar builds upon foundational pharmacogenomics (PGx) knowledge, focusing on how drug metabolism, transport, and elimination are affected when multiple medications interact. You will gain practical insights into how PGx testing can optimise treatment decisions, reduce adverse drug reactions (ADR), and enhance patient safety.
22nd July 2025
Time: 12:30pm
Duration: 45 mins
Audience
Doctors
Medical Professionals
Understand key enzyme pathways and their impact on drug metabolism.
Identify common drug-drug interactions and their clinical consequences.
Learn how CYP2D6, CYP3A4, and CYP2C19 affect medication efficacy.
Explore real-world examples from psychiatry, cardiology, and pain management.
Apply PGx insights to reduce ADRs and personalise prescribing.
Receive a Certificate of Attendance for CPD recognition.
This advanced CPD webinar builds upon foundational pharmacogenomics (PGx) knowledge, focusing on how drug metabolism, transport, and elimination are affected when multiple medications interact. You will gain practical insights into how PGx testing can optimise treatment decisions, reduce adverse drug reactions (ADR), and enhance patient safety.